Auswahl der wissenschaftlichen Literatur zum Thema „Vitiligo surgery“

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Vitiligo surgery" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Vitiligo surgery"

1

Ashwini, PK, DJ Sushmitha und S. Veeranna. „Vitiligo with special emphasis on vitiligo surgery“. Archives of Medicine and Health Sciences 8, Nr. 1 (2020): 140. http://dx.doi.org/10.4103/amhs.amhs_50_20.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Mulekar, SanjeevV. „Evolution of vitiligo surgery“. Pigment International 3, Nr. 2 (2016): 61. http://dx.doi.org/10.4103/2349-5847.196292.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Nahhas, Amanda F., Tasneem F. Mohammad und Iltefat H. Hamzavi. „Vitiligo Surgery: Shuffling Melanocytes“. Journal of Investigative Dermatology Symposium Proceedings 18, Nr. 2 (Oktober 2017): S34—S37. http://dx.doi.org/10.1016/j.jisp.2017.01.001.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Mulekar, Sanjeev V., Ahmed Al Issa, Marwan Asaad, Bassel Ghwish und Abdullah Al Eisa. „Mixed Vitiligo“. Journal of Cutaneous Medicine and Surgery 10, Nr. 2 (März 2006): 104–7. http://dx.doi.org/10.2310/7750.2006.00018.

Der volle Inhalt der Quelle
Annotation:
Background: There are two commonly recognized forms of vitiligo—generalized and localized. This classification is important to understand the course of the disease and its prognosis. Most patients have generalized vitiligo; few patients have both segmented and generalized vitiligo. Observation: We report four more cases of mixed vtiligo, segmental with generalized type. This report is only the second to present a case of segmental with generalized vitiligo. Conclusion: Mixed vitiligo is not yet part of a standard classification. Its etiology is not yet fully defined. Further research is required to understand the course and prognosis of mixed vitiligo.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Khurrum, Huma, und Khalid M. AlGhamdi. „The Relationship Between the Serum Level of Vitamin D and Vitiligo“. Journal of Cutaneous Medicine and Surgery 20, Nr. 2 (12.10.2015): 139–45. http://dx.doi.org/10.1177/1203475415610071.

Der volle Inhalt der Quelle
Annotation:
Background: Low vitamin D levels have been associated with several autoimmune diseases. Vitiligo could be associated with low vitamin D levels. Objective: To determine the level of serum vitamin D in vitiligo patients compared to controls and reveal the possible association of vitamin levels with the pathogenesis of vitiligo. Patients and Methods: A case-controlled study was conducted. After excluding factors that may affect serum vitamin D levels, blood samples were taken from vitiligo patients and controls. The association between vitamin D levels and various vitiligo subgroups (duration of vitiligo, site of onset, age, etc) was measured and correlated. Results: A total of 150 vitiligo patients, 90 (60%) males with a mean age of 30.6 ± 11.4 years, were recruited. The study also had 150 age- and gender-matched vitiligo-free control subjects. There was no significant difference in median serum vitamin D levels between the cases and the controls ( P = .25). The serum levels of vitamin D of the vitiligo patients were found to be lower in males ( P = .01), the younger age group ( P = .01), and patients not treated with ultraviolet (UV) treatment ( P = .01). Conclusion: There is no difference between the vitamin D levels of the vitiligo patients and the control subjects. However, deficiency of 25(OH)D levels within the vitiligo subgroups may be linked to younger age, male gender, short duration of vitiligo, and non-use of phototherapy.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Yazdanpanah, Mohammad Javad, Seyed Ali Seyedi Noghabi, Morteza Taghavi, Monavar Afzal Aghaee und Naghmeh Zabolinejad. „Comparison of Autoimmune Thyroid Disease in Patients With Progressive and Stable Vitiligo“. Journal of Cutaneous Medicine and Surgery 20, Nr. 2 (28.08.2015): 135–38. http://dx.doi.org/10.1177/1203475415604551.

Der volle Inhalt der Quelle
Annotation:
Background and Objective: Activity of vitiligo has not been considered as a patient selection criteria in previous studies; we decided to compare the presence of elevated thyroid auto-antibodies in patients with progressive and stable vitiligo. Methods: Seventy-two patients with vitiligo were examined for thyroid problems and were divided into 2 groups of stable and progressive vitiligo according to their history and physical examination. Anti-thyroid peroxidase antibodies (anti-TPO antibodies), thyroxine (T4), and thyroid stimulating hormone (TSH) levels were assessed for all patients. Results: Elevated levels of anti-TPO antibodies were observed in 43.7% of the patients with stable vitiligo and in 37.5% of patients with progressive vitiligo, which was not statistically significant ( P = .315). Conclusion: This study not only confirmed thyroid dysfunction in patients with vitiligo but also showed that there was no difference in thyroid dysfunction and anti-TPO antibody levels in the subgroups of patients with stable or progressive vitiligo.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Alghamdi, Khalid M., Noura A. Moussa, Ahmed Mandil, Maha Alkofidi, Abdulaziz Madani, Nojoud Aldaham und Abbas A. Alkamel. „Public Perceptions and Attitudes Toward Vitiligo“. Journal of Cutaneous Medicine and Surgery 16, Nr. 5 (September 2012): 334–40. http://dx.doi.org/10.1177/120347541201600510.

Der volle Inhalt der Quelle
Annotation:
Background: Previous studies have discussed attitudes of vitiligo patients toward their disease. However, no studies have addressed this issue from the public's point of view. Objective: To explore the perceptions, attitudes, and misconceptions of the public toward vitiligo. Methods: A self-administered questionnaire was distributed to attendees of primary health care centers in Riyadh, Saudi Arabia, between January and August 2010. Results: Overall, 924 of the 1,000 distributed questionnaires were returned, and 429 were males (46.8%). Moreover, 33.1% (303 of 916) believed that vitiligo is contagious or did not know that it is not. The cause of vitiligo was thought to be infectious by 20.4% of respondents (182 of 894), inherited by 40.5% (365 of 902), autoimmune by 41.2% (370 of 899), and due to a lack of hygiene by 22.5% (199 of 883). Unmarried individuals and those with less education were more likely to state that vitiligo is caused by an infection ( p = .02, p = .03, respectively). Younger individuals and those with less education were more likely to think that vitiligo is caused by a lack of hygiene ( p = .01, p = .001, respectively). More than half of the participants (56.1%, 504 of 898) would be unwilling to marry a vitiligo patient. Younger individuals and males were less likely to marry a vitiligo patient ( p = .01, p = .05, respectively), whereas those of lower income were more likely to accept it ( p = .002). Conclusions: Various misconceptions and negative attitudes about vitiligo among the public are prevalent. Educating the public about vitiligo could ultimately lead to better psychosocial well-being of vitiligo patients. Contexte: Des études ont déjà porté sur la perception des personnes atteintes de vitiligo à l'égard de leur propre maladie, mais aucune étude n'a porté sur la perception du public à l'égard de cette maladie. Objectif: L'étude visait à analyser les perceptions, les attitudes, et les idées fausses du public à l'égard du vitiligo. Méthodes: Un questionnaire autoadministré a été remis à des personnes présentes dans des centres de soins primaires à Riyad, en Arabie saoudite, entre janvier et août 2010. Résultats: En tout, 924 questionnaires sur 1,000 ont été remis. Sur ce nombre, 429 avaient été remplis par des hommes (46.8%). De plus, 33.1% (303 sur 916) des répondants croyaient que le vitiligo était contagieux ou ne savaient pas qu'il ne l'était pas. Quant à la cause du vitiligo, 20.4% des participants (182 sur 894) croyaient que c'était une maladie contagieuse; 40.5% (365 sur 902), que c'était une maladie héréditaire; 41.2% (370 sur 899), que c'était une maladie auto-immune; et 22.5% (199 sur 883), que c'était une maladie due à un manque d'hygiène. Les personnes célibataires et celles moins instruites étaient plus portées à croire que le vitiligo était causé par une infection ( p = .02 et p = .03, respectivement). Les jeunes et les personnes moins instruites étaient plus susceptibles de croire que le vitiligo était causé par un manque d'hygiène ( p = .01 et p = .001, respectivement). Plus de la moitié des participants (56.1%, 504 sur 898) ne voulaient pas se marier avec une personne atteinte de vitiligo. Les jeunes et les hommes étaient moins disposés à se marier avec une personne atteinte de vitiligo ( p = .01 et p = .05, respectivement), tandis que ceux à faible revenu étaient plus susceptibles d'accepter le fait ( p = .002). Conclusions: Il existe plusieurs idées fausses sur le vitiligo au sein de la population, et la maladie suscite des réactions négatives. L'éducation du public sur le vitiligo pourrait peut-être améliorer le bien-être psychosocial des personnes atteintes de vitiligo.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Hann, Seung-Kyung, Dunlu Chen und Jean-Claude Bystryn. „Systemic Steroids Suppress Antimelanocyte Antibodies in Vitiligo“. Journal of Cutaneous Medicine and Surgery 1, Nr. 4 (April 1997): 193–95. http://dx.doi.org/10.1177/120347549700100403.

Der volle Inhalt der Quelle
Annotation:
Background: Vitiligo is associated with autoantibodies to melanocytes. The role of these antibodies in the pathogenesis of the disease is still unknown. Objective: The purpose of this study was to examine the role of vitiligo antibodies in the pathogenesis of the disease by studying whether or not there is a correlation between changes in their level and response to therapy with systemic steroid. Methods: Antibodies to the 40 to 45 kD, 75 kD, and 90 kD vitiligo antigens were measured prior to and following systemic steroid therapy in 10 patients with active vitiligo. Results: Four months following initiation of therapy, seven (78%) of nine patients with good clinical response to steroid treatment had a significant decrease in the level of vitiligo antibodies. By contrast, one patient who had no response to treatment had a slight increase in antibody levels. Conclusion: These findings suggest that one mechanism by which corticosteroids can cause repigmentation in vitiligo is by decreasing the level of vitiligo antibodies, and support the notion that vitiligo antibodies are involved in the pathogenesis of this disease.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Kanwar, Amrinder J., Rahul Mahajan und Davinder Parsad. „Effect of Age at Onset on Disease Characteristics in Vitiligo“. Journal of Cutaneous Medicine and Surgery 17, Nr. 4 (Juli 2013): 253–58. http://dx.doi.org/10.2310/7750.2013.12075.

Der volle Inhalt der Quelle
Annotation:
Background: Vitiligo is a multifactorial disease in which genetic, immunologic, and environmental factors play an important part. Late-onset vitiligo is a poorly defined entity. Materials and Methods: Case records of patients who attended the pigmentary clinic at our institute from January 2001 to December 2010 were reviewed. Patients with a diagnosis of vitiligo were analyzed with respect to their demographic characteristics with special reference to their age at onset. Results: Patients with disease onset after 30 years had a significantly higher association with precipitating factors such as trauma, stress, and drugs in comparison with early-onset vitiligo ( p < .004). However, the difference did not reach statistical significance when these factors were analyzed individually. There was a significantly higher association with other nonautoimmune diseases ( p = .05), a higher incidence of positive family history ( p < .0001), and a higher association with leukotrichia ( p < .002) in late-onset disease. Early-onset nonsegmental vitiligo was associated with a higher incidence of photosensitivity and pruritus compared to early-onset segmental vitiligo. Conclusion: Late-onset vitiligo has certain distinguishing features compared to early-onset vitiligo.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Yu, Richard, Yuanshen Huang, Xuejun Zhang und Youwen Zhou. „Potential Role of Neurogenic Inflammatory Factors in the Pathogenesis of Vitiligo“. Journal of Cutaneous Medicine and Surgery 16, Nr. 4 (Juli 2012): 230–44. http://dx.doi.org/10.1177/120347541201600404.

Der volle Inhalt der Quelle
Annotation:
Background: Vitiligo is a highly complex multifactorial condition of the skin that has an unclear mechanism of pathogenesis. Objective: This review summarizes the role of various neurogenic inflammatory factors significantly upregulated in vitiligo. Methods: A literature review was conducted of all pertinent data regarding neuropeptides that are altered in vitiligo and their possible role in the destruction of melanocytes. Results: The close associations between the skin, immune system, and nervous system, along with specific changes demonstrated in vitiligo patients, support a pathogenic mechanism of vitiligo that involves neuroimmunologic factors, the release of which can be governed by mental stress. Conclusion: Neuropeptides and nerve growth factors are critical regulators of emotional response and may precipitate the onset and development of vitiligo in certain predisposed individuals. More studies are required to investigate whether a direct link exists between genetics, mental stress, and neurogenic factors in vitiligo.
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Dissertationen zum Thema "Vitiligo surgery"

1

Ahmed, Refat Maggi. „Improving the Success of Melanocyte Keratinocyte Transplantation Surgery in Vitiligo; The Role of JAK Inhibitors, and Ablative Laser Resurfacing“. eScholarship@UMMS, 2021. https://escholarship.umassmed.edu/gsbs_diss/1143.

Der volle Inhalt der Quelle
Annotation:
The Melanocyte Keratinocyte Transplantation Procedure (MKTP) is an effective surgical replacement of lost melanocytes in recalcitrant vitiligo and pigmentary skin disorders. However, it is only effective in stable vitiligo lesions because active autoimmunity destroys the newly transplanted melanocytes. Despite careful selection of candidates based on the reported clinical stability, the success of the procedure is still unpredictable. MKTP candidates with non-segmental, segmental, and mixed vitiligo, as well as hypopigmented scars and Piebaldism patients were enrolled to our studies. Our aim was first, to investigate the possible immunological mechanisms responsible for the unpredictable post- transplantation outcomes, including T cell subsets and inflammatory chemokines, by correlating these biomarkers with clinical phenotypes, duration of stability, and surgical outcomes. We used suction blister biopsy, a minimally invasive technique that we developed to sample human skin. Moreover, we quantified transplanted melanocytes in the suspension using flow cytometry. Following MKTP, we corelated these biomarkers to the repigmentation score. We found that CD8+ T cells remain in some clinically stable vitiligo lesions, correlate negatively with the post-surgical score of repigmentation, and inversely impact the durability of the responses. Interestingly, the number of transplanted melanocytes in the suspension and the duration of stability do not have prognostic roles. Based on our findings and in a second group of patients, we suppressed the activity of T cells to enhance the outcomes of MKTP. We used Ruxolitinib, JAK1/2 inhibitor, in a triple blinded randomized controlled within subject study, in comparison with Tacrolimus (a calcineurin inhibitor and the standard of care treatment in vitiligo) as well as placebo control. We found lower T cell infiltrate, lower chemokines, and better skin repigmentation in lesions treated with MKTP plus Ruxolitinib or Tacrolimus than in lesions treated with MKTP plus placebo. Lastly, we compared two different types of laser in preparation of the recipient skin for MKTP - ablative versus fractional Er:YAG laser. We found that the ablative laser is combined with minimal CD8+ T cell epidermal infiltrate and superior repigmentation score in comparison to more infiltrate and lower repigmentation score with the fractional laser. Taken together, these results from our studies provide novel insight to predict the optimal surgical candidates and will improve surgical outcomes. It advances the treatment of vitiligo by uncovering the impact of autoimmunity on the success of repigmentation and discovering new approaches to optimize the surgical treatment options in patients with vitiligo and pigmentary skin disorders.
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bücher zum Thema "Vitiligo surgery"

1

Gupta, Devendra K. Microskin grafting for vitiligo. Dordrecht: Springer, 2009.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

(Editor), Somesh Gupta, Mats J. Olsson (Editor), Amrinder J. Kanwar (Editor) und Jean-Paul Ortonne (Editor), Hrsg. Surgical Management of Vitiligo. Blackwell Publishing Limited, 2006.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Buchteile zum Thema "Vitiligo surgery"

1

Zaiac, Martin N., Andrea Federico Chen und Christopher Spock. „Laser Treatment of Psoriasis, Vitiligo, and Alopecia Areata“. In Dermatologic Surgery, 337–40. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781118412633.ch46.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Khunger, Niti, Koushik Lahiri und Venkataram Mysore. „Vitiligo Surgery“. In Surgery of the Skin, 683–92. Elsevier, 2010. http://dx.doi.org/10.1016/b978-0-323-06575-7.00042-0.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Kachawa, Dilip. „Vitiligo Surgery: An Overview“. In Dermatologic Surgery Made Easy, 35. Jaypee Brothers Medical Publishers (P) Ltd., 2006. http://dx.doi.org/10.5005/jp/books/10199_3.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Venkataram, Mysore, und Koushik Lahiri. „Overview of Vitiligo Surgery“. In ACS(I) Textbook on Cutaneous and Aesthetic Surgery, 325. Jaypee Brothers Medical Publishers (P) Ltd., 2012. http://dx.doi.org/10.5005/jp/books/11651_25.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Khunger, Niti, und Alka Goel. „Complications of Vitiligo Surgery“. In ACS(I) Textbook on Cutaneous and Aesthetic Surgery, 375. Jaypee Brothers Medical Publishers (P) Ltd., 2012. http://dx.doi.org/10.5005/jp/books/11651_32.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Venkataram, Mysore, und Koushik Lahiri. „Overview of Vitiligo Surgery“. In ACS(I) Textbook of Cutaneous and Aesthetic Surgery (2 Volumes), 399. Jaypee Brothers Medical Publishers (P) Ltd., 2018. http://dx.doi.org/10.5005/jp/books/14122_34.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Paul, Munish. „Vitiligo Surgery: Mega Sessions“. In ACS(I) Textbook of Cutaneous and Aesthetic Surgery (2 Volumes), 442. Jaypee Brothers Medical Publishers (P) Ltd., 2018. http://dx.doi.org/10.5005/jp/books/14122_39.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Khunger, Niti, und Alka Goel. „Complications of Vitiligo Surgery“. In ACS(I) Textbook of Cutaneous and Aesthetic Surgery (2 Volumes), 481. Jaypee Brothers Medical Publishers (P) Ltd., 2018. http://dx.doi.org/10.5005/jp/books/14122_46.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Shenoi, Shruti. „Punch Grafting in Vitiligo“. In Dermatologic Surgery Made Easy, 67. Jaypee Brothers Medical Publishers (P) Ltd., 2006. http://dx.doi.org/10.5005/jp/books/10199_5.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Lahiri, Koushik. „Minigrafting for Vitiligo“. In ACS(I) Textbook of Cutaneous and Aesthetic Surgery (2 Volumes), 408. Jaypee Brothers Medical Publishers (P) Ltd., 2018. http://dx.doi.org/10.5005/jp/books/14122_35.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Vitiligo surgery"

1

Lentsch, Griffin R., Mihaela Balu, Karsten Koenig, Seongjin Jo, Bruce J. Tromberg und Anand Ganesan. „In vivo multiphoton microscopy imaging of vitiligo (Conference Presentation)“. In Photonics in Dermatology and Plastic Surgery 2019, herausgegeben von Bernard Choi und Haishan Zeng. SPIE, 2019. http://dx.doi.org/10.1117/12.2508791.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Zhao, Jianhua, Vincent Richer, Mohammed Al Jasser, Soodabeh Zandi, Nikiforos Kollias, Sunil Kalia, Haishan Zeng und Harvey Lui. „Fluorescence excitation-emission matrix spectroscopy of vitiligo skin in vivo (Conference Presentation)“. In Photonics in Dermatology and Plastic Surgery, herausgegeben von Bernard Choi, Haishan Zeng und Nikiforos Kollias. SPIE, 2016. http://dx.doi.org/10.1117/12.2214210.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Lentsch, Griffin R., Jessica Shiu, Jessica Flesher, Pezhman Mobasher, Christopher Polleys, Craig Mizzoni, Karsten König et al. „In-vivo optical microscopy and single cell transcriptomics approaches provide insights into therapeutic response of vitiligo“. In Photonics in Dermatology and Plastic Surgery 2021, herausgegeben von Bernard Choi und Haishan Zeng. SPIE, 2021. http://dx.doi.org/10.1117/12.2582167.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Lentsch, Griffin R., Pezhman Mobasher, Craig Mizzoni, Karsten Koenig, Bruce Tromberg, Irene Georgakoudi, Anand Ganesan und Mihaela Balu. „In vivo optical imaging of vitiligo skin grafting treatment using multiphoton microscopy and reflectance confocal microscopy (Conference Presentation)“. In Photonics in Dermatology and Plastic Surgery 2020, herausgegeben von Bernard Choi und Haishan Zeng. SPIE, 2020. http://dx.doi.org/10.1117/12.2544056.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Verdaasdonk, Rudolf M., Sanne Uitentuis, M. Heilman, J. M. Bae, Rosalie Luiten, Albert Wolkerstorfer und Marcel Bekkenk. „A full spectral modified 'UV camera' for improving the assessment and quantification of vitiligo lesions compared to conventional photography (Conference Presentation)“. In Photonics in Dermatology and Plastic Surgery 2020, herausgegeben von Bernard Choi und Haishan Zeng. SPIE, 2020. http://dx.doi.org/10.1117/12.2547510.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Kohli, Indermeet, Alexis B. Lyons, Raheel Zubair, Bhavnit Bhatia, Amanda F. Nahhas, Taylor L. Braunberger, Henry W. Lim und Iltefat H. Hamzavi. „Optimizing parameters for inducing repigmentation in subjects with generalized vitiligo: comparing the efficacy of visible light with ultraviolet A1 versus narrowband ultraviolet B (Conference Presentation)“. In Photonics in Dermatology and Plastic Surgery 2020, herausgegeben von Bernard Choi und Haishan Zeng. SPIE, 2020. http://dx.doi.org/10.1117/12.2544864.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie